Compare LOVE & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LOVE | STXS |
|---|---|---|
| Founded | 1998 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 227.3M | 190.6M |
| IPO Year | 2018 | 2004 |
| Metric | LOVE | STXS |
|---|---|---|
| Price | $14.57 | $1.88 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $25.00 | $4.00 |
| AVG Volume (30 Days) | 170.5K | ★ 345.6K |
| Earning Date | 06-11-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 16.67 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $697,115,000.00 | $29,346,617.00 |
| Revenue This Year | $4.63 | $28.22 |
| Revenue Next Year | $6.40 | $30.47 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 2.42 | N/A |
| 52 Week Low | $10.33 | $1.70 |
| 52 Week High | $20.88 | $3.59 |
| Indicator | LOVE | STXS |
|---|---|---|
| Relative Strength Index (RSI) | 39.66 | 50.95 |
| Support Level | $14.43 | $1.74 |
| Resistance Level | $15.59 | $1.99 |
| Average True Range (ATR) | 0.89 | 0.09 |
| MACD | -0.22 | -0.00 |
| Stochastic Oscillator | 18.56 | 52.00 |
The Lovesac Co designs, manufactures and sells alternative furniture which is comprised of modular couches called sactionals and premium foam beanbag chairs called sacs. It also offers other accessories such as sactional-specific drink holders, Footsac blankets, decorative pillows, fitted seat tables, and ottomans. Its products are sold across the United States through its website or company-owned retail stores which are used in homes and offices. The majority of the firm's revenue is derived from the sale of Sactionals.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.